| Table 2: | |||
|
Usual
Dosages for Long-Term-Control Medications
|
|||
|
Medication
|
Dosage
Form
|
Adult
Dose
|
Child
Dose*
|
| Inhaled Corticosteroids (See Estimated Comparative Daily Dosages for Inhaled Corticosteroids-Table 3) | |||
| Systemic Corticosteroids (Applies to all three corticosteroids) | |||
| Methylprednisone | 2,4,8,16, 32 mg tablets |
|
|
| Prednisolone |
5 mg tablets, 5 mg/5
mL, 15 |
||
| Prednisone |
1, 2.5, 5, 10, 20, 50 mg tablets; 5 mg/mL, 5 mg/mL |
||
| Long-acting Inhaled Beta2-Agonists (Should not be used for symptom relief or for exacerbations. Use with inhaled corticosteroids.) | |||
| Salmeterol | MDI 21 µg/puff DPI 50 µg/blister |
2
puffs q 12 hours 1 blister q 12 hours |
1-2
puffs q 12 hours 1 blister q 12 hours |
| Formoterol | DPI 12 µg/single-use capsule |
1 capsule q 12 hours | 1 capsule q 12 hours |
| Combined Medication | |||
| Fluticasone/Salmeterol | DPI 100, 250, or 500 µg/50µg |
1 inhalation bid; dose depends on severity of asthma | 1 inhalation bid; dose depends on severity of asthma |
| Cromolyn and Nedocromil | |||
| Cromolyn | MDI 1 mg/puff nebulizer 20 mg/ampule |
2-4
puffs tid-qid 1 ampule tid-qid |
1-2
puffs tid-qid 1 ampule tid-qid |
| Nedocromil | MDI 1.75 mg/puff |
2-4 puffs bid-qid | 1-2 puffs bid-qid |
| Leukotriene Modifiers | |||
| Montelukast | 4
or 5 mg chewable tablet 10 mg tablet |
10 mg qhs | 4
mg qhs (2-5 yrs) 5 mg qhs (6-14 yrs) 10 mg qhs (>14 yrs) |
| Zafirlukast | 10 or 20 mg tablet | 40 mg daily (20 mg tablet bid) | 20 mg daily (7-11 yrs)(10 mg tablet bid) |
| Zileuton | 300 or 600 mg tablet | 2,400 mg daily (give tablets qid) | |
| Methylxanthines (Serum monitoring is important [serum concentration of 5-15 µg/mL at steady state]). | |||
| Theophylline | Liquids, sustained- release tablets, and capsules | Starting dose 10 mg/kg/day up to 300 mg max; usual max 800 mg/day |
Starting dose 10 mg/kg/day;
usual max:
|
|
Copyright
2003 The Cleveland Clinic Foundation
|